EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T‐Cell Lymphoma: Clinical Utility and Pitfalls Related to T‐Cell Clones of Uncertain Significance

SooHo Yu iD, Boram Kim iD, Sang Eun Yoon iD, Hee-Jin Kim iD, Hyun-Young Kim iD

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.14508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von SooHo Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Flow Cytometry, Lymphoma, T-Cell, Biomarkers, Tumor, Receptors, Antigen, T-Cell, alpha-beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

T‐cell receptor constant beta chain 1 (TRBC1) has emerged as a potential clonal marker for T‐cell lymphoma. This study evaluated TRBC1 expression using flow cytometry in healthy individuals and various clinical specimens, assessing its clinical utility in the diagnosis of T‐cell lymphomas.

Methods

Flow cytometric analysis was performed on peripheral blood specimens from 20 healthy individuals and 186 clinical specimens (116 bone marrow aspirates, 18 peripheral bloods, 52 body fluids) from 177 patients for the exclusion or differential diagnosis of T‐cell lymphoma using a panel of nine monoclonal antibodies: CD45, CD3, CD4, CD8, CD56, CD2, CD5, CD7, and TRBC1.

Results

TRBC1 showed polytypic expression in healthy individuals with a median of 38.6% (range, 33.9%–46.1%) in CD4+ T cells and 26.3% (range, 10.9%–44.2%) in CD8+ T cells ( p < 0.001). TRBC1 expression in non‐T‐cell lymphoma specimens was comparable to that in healthy peripheral blood, except for bone marrow, which showed slightly higher TRBC1 expression. All 20 T‐cell lymphoma cases exhibited monotypic TRBC1 expression, with a predominance of TRBC1− (65%). Additionally, T‐cell clones of uncertain significance (TCUS) were detected in 12.7% of non‐T‐cell lymphoma specimens, predominantly in CD8+ T cells and associated with cytopenic and reactive conditions.

Conclusions

This study demonstrates the clinical utility of flow cytometric TRBC1 assessment in diagnosing T‐cell lymphomas, characterizing TRBC1 expression patterns, and identifying TCUS in a large cohort of specimens without T‐cell lymphoma involvement across diverse clinical settings. Given the relatively frequent detection of TCUS, these findings underscore the importance of interpreting TRBC1 flow cytometry results within the appropriate clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryLymphoma, T-CellBiomarkers, TumorReceptors, Antigen, T-Cell, alpha-betaHumansMaleFemaleMiddle AgedAdultAgedImmunophenotypingAged, 80 and overDiagnosis, Differential

Stichwörter der Autor:innen

TRBC1T‐cell clones of uncertain significanceT‐cell lymphomasT‐cell receptor constant beta chain 1flow cytometry

Substanzen

Biomarkers, TumorReceptors, Antigen, T-Cell, alpha-beta

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: SooHo Yu, Boram Kim, Sang Eun Yoon, Hee-Jin Kim, Hyun-Young Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Yu, S., Kim, B., Yoon, S. E., Kim, H. J., & Kim, H. Y. (2025). Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T‐Cell Lymphoma: Clinical Utility and Pitfalls Related to T‐Cell Clones of Uncertain Significance. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14508

Vancouver

Yu S, Kim B, Yoon SE, Kim HJ, Kim HY. Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T‐Cell Lymphoma: Clinical Utility and Pitfalls Related to T‐Cell Clones of Uncertain Significance. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14508

BibTeX
@article{Yu2025,
  author = {Yu, SooHo and Kim, Boram and Yoon, Sang Eun and Kim, Hee-Jin and Kim, Hyun-Young},
  title = {Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T‐Cell Lymphoma: Clinical Utility and Pitfalls Related to T‐Cell Clones of Uncertain Significance},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.14508}
}
Kostenlos starten →